VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
VERAXA Biotech appointed Raju Willener as Chief Financial Officer, effective immediately, reporting to CEO and co-founder Christoph Antz. Willener brings more than three decades of global capital markets and corporate finance experience, most recently as CFO of Exentis Group AG, and earlier oversaw investment portfolios exceeding CHF 30 billion in assets under management.
Key figures
- Cfo experience years
- 30+
- Prior portfolios aum
- CHF 30 billion
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.